Sanjivani Paranteral Ltd

Sanjiv.Parant. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Sanjivani Paranteral Ltd

₹ 149 -0.93%
24 Jul - close price
sanjivani.co.in BSE: 531569
About

Incorporated in 1994, Sanjivani Parenteral Ltd is a research-based and export-oriented pharmaceutical company[1]

Key Points

Business Overview:[1][2]
SPL is a WHO-GMP, DIGEMID, and
DDA-certified pharmaceutical company specializing in high-quality parenteral and
oral solid formulations. It serves key therapeutic areas including CNS, CVS, antibiotics, urology, anesthetics, gastro enterology, anti-diabetics, anti-fungals, anti-depressants, anti-allergics, muscle relaxants, and vitamin supplements.

Website BSE
  • Market Cap ₹ 183 Cr.
  • Current Price ₹ 149
  • High / Low ₹ 269 / 126
  • Stock P/E 26.4
  • Book Value ₹ 39.4
  • Dividend Yield 0.34 %
  • ROCE 19.3 %
  • ROE 16.0 %
  • Face Value ₹ 10.0
Edit ratios

Pros

Cons

  • Promoter holding is low: 31.6%
  • Working capital days have increased from 87.6 days to 143 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
8.12 12.58 14.00 14.96 12.86 16.44 18.13 17.35 18.18 17.89 15.50 20.86 10.51
6.69 10.57 11.88 12.99 10.70 14.10 15.28 14.80 15.57 15.25 13.25 17.26 9.60
Operating Profit 1.43 2.01 2.12 1.97 2.16 2.34 2.85 2.55 2.61 2.64 2.25 3.60 0.91
OPM % 17.61% 15.98% 15.14% 13.17% 16.80% 14.23% 15.72% 14.70% 14.36% 14.76% 14.52% 17.26% 8.66%
-0.04 0.06 0.15 0.25 0.05 0.09 0.39 0.31 0.43 0.04 0.16 0.29 0.75
Interest 0.16 0.04 0.05 0.08 0.09 0.02 0.18 0.19 0.20 0.22 0.05 0.21 0.06
Depreciation 0.23 0.23 0.23 0.24 0.24 0.13 0.15 0.16 0.18 0.16 0.17 0.19 0.35
Profit before tax 1.00 1.80 1.99 1.90 1.88 2.28 2.91 2.51 2.66 2.30 2.19 3.49 1.25
Tax % 0.00% 13.89% 14.07% 13.16% 33.51% 24.56% 21.31% 24.30% 17.29% 24.78% 25.11% 24.93% 25.60%
1.00 1.55 1.71 1.65 1.26 1.71 2.30 1.90 2.19 1.73 1.64 2.62 0.94
EPS in Rs 1.00 1.55 1.71 1.65 1.08 1.46 1.97 1.60 1.84 1.43 1.34 2.13 0.77
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
133.03 115.31 32.53 17.96 25.09 16.29 25.09 30.59 41.45 54.41 70.10 64.76
127.71 120.84 55.81 70.17 26.85 16.62 22.95 24.86 35.80 46.18 59.74 55.36
Operating Profit 5.32 -5.53 -23.28 -52.21 -1.76 -0.33 2.14 5.73 5.65 8.23 10.36 9.40
OPM % 4.00% -4.80% -71.56% -290.70% -7.01% -2.03% 8.53% 18.73% 13.63% 15.13% 14.78% 14.52%
1.24 0.73 2.85 0.48 0.96 0.25 0.26 0.24 0.54 0.52 1.21 1.24
Interest 7.92 8.81 4.79 0.45 0.33 0.66 0.13 0.21 0.36 0.25 0.59 0.54
Depreciation 1.41 1.36 1.20 1.19 1.17 1.07 0.86 0.88 0.89 0.93 0.62 0.86
Profit before tax -2.77 -14.97 -26.42 -53.37 -2.30 -1.81 1.41 4.88 4.94 7.57 10.36 9.24
Tax % -13.00% -2.20% -0.72% -0.60% -10.00% -5.52% -0.71% 0.61% 8.70% 18.63% 21.81% 25.00%
-2.41 -14.64 -26.22 -53.06 -2.07 -1.71 1.42 4.85 4.51 6.17 8.10 6.92
EPS in Rs -4.09 -24.82 -44.45 -89.96 -3.51 -2.90 1.67 4.85 4.51 5.28 6.82 5.63
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 7.33% 0.00%
Compounded Sales Growth
10 Years: -6%
5 Years: 21%
3 Years: 16%
TTM: -8%
Compounded Profit Growth
10 Years: 9%
5 Years: 37%
3 Years: 15%
TTM: -15%
Stock Price CAGR
10 Years: 20%
5 Years: 38%
3 Years: 28%
1 Year: -35%
Return on Equity
10 Years: %
5 Years: %
3 Years: 24%
Last Year: 16%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 5.90 5.90 5.90 5.90 5.90 5.90 8.50 10.00 10.00 11.68 11.88 12.28
Reserves 26.24 11.60 -14.62 -58.72 -53.10 -54.81 -53.39 -17.58 -13.07 16.22 26.12 36.10
57.06 62.20 59.89 48.23 48.09 48.91 46.05 6.00 2.49 0.97 5.62 9.15
24.48 13.42 9.15 29.61 17.09 15.66 18.11 19.87 21.59 14.53 21.37 20.90
Total Liabilities 113.68 93.12 60.32 25.02 17.98 15.66 19.27 18.29 21.01 43.40 64.99 78.43
13.52 12.69 11.19 10.17 8.99 8.04 7.62 7.42 7.57 9.94 20.56 23.23
CWIP 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Investments 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.00 3.00 4.64
100.10 80.38 49.08 14.80 8.94 7.57 11.60 10.82 13.39 33.46 41.43 50.56
Total Assets 113.68 93.12 60.32 25.02 17.98 15.66 19.27 18.29 21.01 43.40 64.99 78.43

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
-1.20 0.45 9.57 3.05 2.48 -0.17 0.58 8.52 4.68 -10.70 -0.24 -1.55
8.68 -0.50 0.30 -0.20 0.02 -0.12 -0.42 -0.67 -0.99 -12.21 -5.81 -4.47
-7.30 -0.51 -10.05 -2.83 -2.30 0.33 -0.26 -7.68 -3.73 23.16 6.14 6.54
Net Cash Flow 0.18 -0.57 -0.18 0.03 0.20 0.03 -0.09 0.17 -0.04 0.24 0.09 0.52
Free Cash Flow 7.47 -0.06 9.87 2.85 2.50 -0.30 0.15 7.84 3.63 -14.00 -11.48 -5.21
CFO/OP -23% -8% -41% -6% -143% 48% 28% 150% 84% -117% 10% 6%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 184.24 151.59 358.38 107.71 75.79 23.97 96.45 58.71 17.52 31.53 86.85 62.05
Inventory Days 68.59 65.35 127.41 34.08 13.56 66.80 22.43 51.89 105.21 124.70 93.96 83.05
Days Payable 37.50 19.51 42.51 169.13 292.82 434.62 261.00 339.20 269.82 73.56 137.51 101.33
Cash Conversion Cycle 215.34 197.43 443.28 -27.33 -203.47 -343.84 -142.12 -228.61 -147.08 82.67 43.30 43.77
Working Capital Days 61.38 26.72 -196.58 -1,285.22 -714.43 -1,162.44 -707.31 -173.01 -129.27 35.55 83.73 143.38
ROCE % 5.95% -7.31% -35.52% -227.18% -258.43% 265.52% 55.28% 30.21% 19.34%

Insights

In beta
Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Export Revenue Share
%

Log in to view insights

Please log in to see hidden values.

Login
Product Category Mix - Injectables Revenue Share
%
Installed Annual Capacity - Ampoules
million units per annum
Installed Annual Capacity - Capsules
million units per annum
Installed Annual Capacity - Tablets
million units per annum
Region-wise Mix - Latin America Revenue Share
%
Region-wise Mix - Middle East & Africa Revenue Share
%
IV Plant (Pune) - Installed Capacity
million bottles per annum

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

2 Recently
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
32.34% 32.34% 27.67% 27.67% 27.67% 27.67% 28.87% 28.87% 31.20% 31.20% 31.26% 31.56%
8.16% 6.01% 9.71% 9.36% 6.26% 6.26% 6.15% 6.15% 6.02% 6.03% 6.03% 5.45%
59.51% 61.65% 62.62% 62.98% 66.08% 66.09% 64.97% 64.98% 62.77% 62.76% 62.71% 62.98%
No. of Shareholders 4,5004,5004,9116,1666,7316,6186,4476,4296,2866,0175,9335,880

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls